After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
HUMA belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Humacyte Inc is $594.44M. A total of 1.34 million shares were traded on the day, compared to an average of 4.64M shares.
In the most recent transaction, Constantino Michael T. bought 4,600 shares of HUMA for 4.39 per share on Dec 04 ’24. After the transaction, the Director now owns 16,950 company shares. In a previous transaction on Nov 19 ’24, Niklason Laura E bought 1,797 shares at 4.44 per share. HUMA shares that President, CEO and Director owns now total 243,851.
Among the insiders who bought shares, Dougan Brady W acquired of 1,797 shares on Nov 19 ’24 at a per-share price of $4.44. This resulted in the Director holding 243,851 shares of HUMA after the transaction. In another insider transaction, Niklason Laura E sold 811,172 shares at $4.44 per share on Nov 18 ’24. Company shares held by the President, CEO and Director now total 2,419,712.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, HUMA has a high of $9.97 and a low of $2.81.
As of this writing, HUMA has an earnings estimate of -$0.25 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of -$0.22 per share and a lower estimate of -$0.3.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. HUMA’s latest balance sheet shows that the firm has $225.50M in Cash & Short Term Investments as of fiscal 2021. There were $51.18M in debt and $11.05M in liabilities at the time. Its Book Value Per Share was -$0.53, while its Total Shareholder’s Equity was $122.17M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HUMA is Buy with a score of 4.71.
